140 related articles for article (PubMed ID: 7929528)
1. Antitumour effect of a gonadotropin-releasing-hormone antagonist (MI-1544) and its conjugate on human breast cancer cells and their xenografts.
Vincze B; Pályi I; Daubner D; Kálnay A; Mezö G; Hudecz F; Szekerke M; Teplán I; Mezö I
J Cancer Res Clin Oncol; 1994; 120(10):578-84. PubMed ID: 7929528
[TBL] [Abstract][Full Text] [Related]
2. In vivo studies of the new gonadotropin-releasing hormone antagonist--copolymer conjugates having antitumor activity.
Vincze B; Pályi I; Gaál D; Pató J; Móra M; Mezõ I; Teplán I; Seprõdi J
Cancer Detect Prev; 1996; 20(2):153-9. PubMed ID: 8706041
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, conformation, biodistribution, and hormone-related in vitro antitumor activity of a gonadotropin-releasing hormone antagonist-branched polypeptide conjugate.
Mezö G; Mezö I; Pimm MV; Kajtár J; Seprödi J; Teplán I; Kovács M; Vincze B; Pályi I; Idei M; Szekerke M; Hudecz F
Bioconjug Chem; 1996; 7(6):642-50. PubMed ID: 8950483
[TBL] [Abstract][Full Text] [Related]
4. Effect of gonadotropin-releasing hormone analogs and their conjugates on gonadotropin-releasing hormone receptor--positive human cancer cell lines.
Pályi I; Vincze B; Kálnay A; Turi G; Mezõ I; Teplán I; Seprõdi J; Pató J; Móra M
Cancer Detect Prev; 1996; 20(2):146-52. PubMed ID: 8706040
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and luteinizing hormone-releasing hormone antagonist SB-75 on the growth of MCF-7 MIII human breast cancer xenografts in athymic nude mice.
Yano T; Pinski J; Szepeshazi K; Halmos G; Radulovic S; Groot K; Schally AV
Cancer; 1994 Feb; 73(4):1229-38. PubMed ID: 8313327
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin-releasing hormone analogue conjugates with strong selective antitumor activity.
Pályi I; Vincze B; Lovas S; Mezö I; Pató J; Kálnay A; Turi G; Gaál D; Mihalik R; Péter I; Teplán I; Murphy RF
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2361-6. PubMed ID: 10051647
[TBL] [Abstract][Full Text] [Related]
7. Gonadotropin-releasing hormone type II antagonist induces apoptosis in MCF-7 and triple-negative MDA-MB-231 human breast cancer cells in vitro and in vivo.
Gründker C; Föst C; Fister S; Nolte N; Günthert AR; Emons G
Breast Cancer Res; 2010; 12(4):R49. PubMed ID: 20630060
[TBL] [Abstract][Full Text] [Related]
8. Receptor-mediated targeting of a photosensitizer by its conjugation to gonadotropin-releasing hormone analogues.
Rahimipour S; Ben-Aroya N; Ziv K; Chen A; Fridkin M; Koch Y
J Med Chem; 2003 Sep; 46(19):3965-74. PubMed ID: 12954050
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin analogue RC-160 and LH-RH antagonist SB-75 inhibit growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice.
Radulovic S; Comaru-Schally AM; Milovanovic S; Schally AV
Pancreas; 1993 Jan; 8(1):88-97. PubMed ID: 8093555
[TBL] [Abstract][Full Text] [Related]
10. Peptides and antitumor activity. Development and investigation of some peptides with antitumor activity.
Teplán I
Acta Biol Hung; 2000; 51(1):1-29. PubMed ID: 10866357
[TBL] [Abstract][Full Text] [Related]
11. Direct effects of luteinizing hormone-releasing hormone agonists and antagonists on MCF-7 mammary cancer cells.
Segal-Abramson T; Kitroser H; Levy J; Schally AV; Sharoni Y
Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2336-9. PubMed ID: 1312718
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of growth of OV-1063 human epithelial ovarian cancer xenografts in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75.
Yano T; Pinski J; Halmos G; Szepeshazi K; Groot K; Schally AV
Proc Natl Acad Sci U S A; 1994 Jul; 91(15):7090-4. PubMed ID: 7518926
[TBL] [Abstract][Full Text] [Related]
13. Sustained release formulations of luteinizing hormone-releasing hormone antagonist SB-75 inhibit proliferation and enhance apoptotic cell death of human prostate carcinoma (PC-82) in male nude mice.
Redding TW; Schally AV; Radulovic S; Milovanovic S; Szepeshazi K; Isaacs JT
Cancer Res; 1992 May; 52(9):2538-44. PubMed ID: 1568223
[TBL] [Abstract][Full Text] [Related]
14. Potent pituitary-gonadal axis suppression and extremely low anaphylactoid activity of a new gonadotropin releasing hormone (GnRH) receptor antagonist "azaline B".
Campen CA; Lai MT; Kraft P; Kirchner T; Phillips A; Hahn DW; Rivier J
Biochem Pharmacol; 1995 May; 49(9):1313-21. PubMed ID: 7763313
[TBL] [Abstract][Full Text] [Related]
15. Improved In Vivo Anti-Tumor and Anti-Metastatic Effect of GnRH-III-Daunorubicin Analogs on Colorectal and Breast Carcinoma Bearing Mice.
Ranđelović I; Schuster S; Kapuvári B; Fossati G; Steinkühler C; Mező G; Tóvári J
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31557968
[TBL] [Abstract][Full Text] [Related]
16. Influence of luteinizing hormone-releasing hormone agonists on human mammary carcinoma cell lines and their xenografts.
Vincze B; Pályi I; Daubner D; Kremmer T; Számel I; Bodrogi I; Sugár J; Seprödi J; Mezö I; Teplán I
J Steroid Biochem Mol Biol; 1991 Feb; 38(2):119-26. PubMed ID: 2004034
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, in vitro stability, and antiproliferative effect of d-cysteine modified GnRH-doxorubicin conjugates.
Li S; Zhao H; Chang X; Wang J; Zhao E; Yin Z; Mao X; Deng S; Hao T; Wang H; Yang Y
J Pept Sci; 2019 Jan; 25(1):e3135. PubMed ID: 30467919
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of growth of human mammary tumor cells by potent antagonists of luteinizing hormone-releasing hormone.
Sharoni Y; Bosin E; Miinster A; Levy J; Schally AV
Proc Natl Acad Sci U S A; 1989 Mar; 86(5):1648-51. PubMed ID: 2646641
[TBL] [Abstract][Full Text] [Related]
19. Differential actions of a mammalian gonadotropin-releasing hormone antagonist on gonadotropin-II and growth hormone release in goldfish, Carassius auratus.
Murthy CK; Turner RJ; Wong AO; Rao PD; Rivier JE; Peter RE
Neuroendocrinology; 1994 Jun; 59(6):561-71. PubMed ID: 8084380
[TBL] [Abstract][Full Text] [Related]
20. Compared effects of GnRH analogs and 4-hydroxytamoxifen on growth and steroid receptors in antiestrogen sensitive and resistant MCF-7 breast cancer cell sublines.
Néri C; Berthois Y; Schatz B; Drieu K; Martin PM
Breast Cancer Res Treat; 1990 Feb; 15(2):85-93. PubMed ID: 2138918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]